Clinical trial Recruiting at 1 site Observational

Factors linked to diabetic foot ulcer severity and outcomes

Official title: Examining the Demographic, Clinical, and Laboratory Data of Patients With Diabetic Foot Ulcers Admitted to 5 Azar Hospital in 2024 (Registry Project)

Run by Golestan University of Medical sciences · NCT07188337 · Data updated 2026-11-12

This project looks at records of about 200 people with diabetic foot ulcers treated at 5 Azar Hospital in 2024 to see if blood tests and other health factors link to worse ulcers.

Quick facts

Study typeObservational
SexAll
Enrollment200 (estimated)
SponsorGolestan University of Medical sciences
Academic / other
Locations1 site (Gorgan, Outside of the US)
StatusRecruiting
StartedJuly 27, 2025
Main results expectedOctober 2025
Study endsNovember 2025
Registry record updatedSeptember 23, 2025
Trial IDNCT07188337 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults admitted to 5 Azar Hospital in 2024 with a confirmed diabetic foot ulcer and complete demographic, clinical, and laboratory records are ideal candidates.

Probably not a fit

Patients with incomplete or missing records, non-diabetic foot ulcers, or whose care occurs outside this hospital are unlikely to benefit directly from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional, retrospective analysis will review medical records of approximately 200 patients admitted with diabetic foot ulcers to 5 Azar Hospital, Gorgan, in 2024. Researchers will extract demographic information, clinical features, and laboratory values (hemoglobin, WBC, HbA1c, ESR, CRP) and grade ulcer severity using Wagner's classification. Statistical comparisons (independent t-test, chi-square, Fisher's exact test) and multivariable logistic regression will be used to identify factors associated with greater ulcer severity and adverse outcomes. Findings aim to highlight predictors that could inform prevention and management strategies for diabetic foot ulcers.

Why it matters

Potential benefit: If the study identifies reliable predictors, clinicians could target high-risk patients earlier to reduce infections, hospital stays, and amputations.

How similar studies have gone: Prior observational studies have reported associations between markers like HbA1c, WBC, and inflammatory markers with ulcer severity, so this project builds on existing evidence rather than testing a new treatment.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients admitted to 5 Azar Hospital, Gorgan, in 2024
* Diagnosis of diabetic foot ulcer (DFU) confirmed by medical records
* Complete demographic, clinical, and laboratory data available in medical files

Exclusion Criteria:

* Incomplete or missing medical records
* Patients with foot ulcers of non-diabetic etiology
* Patients whose key laboratory data are unavailable

Where it's running

  • 5Th Azar Medical Center
    Gorgan, Outside of the US, Iran
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.